Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Wenyan Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8108-3463; OpenAlex author ID A5101735275. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper

Papers 2

  1. SETD8 induces stemness and epithelial-mesenchymal transition of pancreatic cancer cells by regulating ROR1 expression. Last author DOI 10.1093/abbs/gmab140↗
  2. UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2019.03.024↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaowu Xu · 2 shared papers, 2019–2021 · strength 0.21
  2. Qiangsheng Hu · 2 shared papers, 2019–2021 · strength 0.21
  3. Mengqi Liu · 2 shared papers, 2019–2021 · strength 0.21
  4. Wensheng Liu · 2 shared papers, 2019–2021 · strength 0.21
  5. Xianjun Yu · 2 shared papers, 2019–2021 · strength 0.21
  6. Shunrong Ji · 2 shared papers, 2019–2021 · strength 0.21
  7. Ye Zeng · 1 shared paper, 2021 · strength 0.12
  8. Qifeng Zhuo · 1 shared paper, 2021 · strength 0.12
  9. Changfeng Song · 1 shared paper, 2021 · strength 0.12
  10. Quanxing Ni · 1 shared paper, 2019 · strength 0.09
  11. Zheng Zhang · 1 shared paper, 2019 · strength 0.09
  12. Qiqing Sun · 1 shared paper, 2019 · strength 0.09
  13. Yi Qin · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.